Prognostic significance of nuclear DJ-1 expression in astrocytoma

Anticancer Research

Volumn 30, Issue 1, 2010, Pages 265-270

  Miyajima, Yoshiteru ^a   Sato, Yuichi ^b   Oka, Hidehiro ^a   Utsuki, Satoshi ^a   Kondo, Koji ^a   Tanizaki, Yoshinori ^a   Nagashio, Ryo ^b,c   Tsuchiya, Benio ^b   Okayasu, Isao ^a   Fujii, Kiyotaka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Astrocytoma; DJ 1; Immunohistochemistry; Prognosis; WHO grading

Indexed keywords

DJ 1 PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; ONCOGENE PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; YOUNG ADULT;

EID: 77649242821     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Hod Y, Pentyala SN, Whyard TC and El-Maghrabi MR: Identification and characterization of a novel protein that regulates RNA-protein interaction. J Cell Biochem 72: 435-444, 1999.
2. Wilson MA, Collins JL, Hod Y, Ringe D and Petsko GA: The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proc Natl Acad Sci USA 100: 9256-9261, 2003.
3. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA and Heutink P: Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259, 2003.
4. Bader V, Ran Zhu X, Lübbert H and Stichel CC: Expression of DJ-1 in the adult mouse CNS. Brain Res 1041: 102-111, 2005.
5. Shang H, Lang D, Jean-Marc B and Kaelin-Lang A: Localization of DJ-1 mRNA in the mouse brain. Neurosci Lett 367: 273-277, 2004.
6. Rizzu P, Hinkle DA, Zhukareva V, Bonifati V, Severijnen LA, Martinez D, Ravid R, Kamphorst W, Eberwine JH, Lee VM, Trojanowski JQ and Heutink P: DJ-1 co-localizes with tau inclusions: a link between parkinsonism and dementia. Ann Neurol 55: 113-118, 2004.
7. Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM, Hope AD, Pittman AM, Lashley T, Canet-Aviles R, Miller DW, McLendon C, Strand C, Leonard AJ, Abou-Sleiman PM, Healy DG, Ariga H, Wood NW, de Silva R, Revesz T, Hardy JA and Lees AJ: The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 127: 420-430, 2003.
8. Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K and Ariga H: DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5: 213-218, 2004.
9. Yokota T, Sugawara K, Ito K, Takahashi R, Ariga H and Mizusawa H: Down-regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. Biochem Biophys Res Commun 312: 1342-1348, 2003.
10. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, Iguchi-Ariga SM and Ariga H: DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 231: 509-513, 1997.
11. Le Naour F, Misek DE, Krause MC et al: Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res 7(11): 3328-3335, 2001.
12. Le Naour F, Misek DE, Krause MC, Deneux L, Giordano TJ, Scholl S and Hanash SM: Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res 63: 6928-6934, 2003.
13. Pardo M, García A, Thomas B, Piñeiro A, Akoulitchev A, Dwek RA and Zitzmann N: The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int J Cancer 119: 1014-1022, 2006.
14. Kotaria N, Hinz U, Zechel S and von Bohlen Und Halbach O: Localization of DJ-1 protein in the murine brain. Cell Tissue Res 322: 503-507, 2005.
15. Davidson B, Hadar R, Schlossberg A, Sternlicht T, Slipicevic A, Skrede M, Risberg B, Flørenes VA, Kopolovic J and Reich R: Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma. Hum Pathol 39: 87-95, 2008.
16. Kim RH, Peters M, Jang Y, Shi W, Pintilie M, Fletcher GC, DeLuca C, Liepa J, Zhou L, Snow B, Binari RC, Manoukian AS, Bray MR, Liu FF, Tsao MS and Mak TW: DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 7: 263-273, 2005.
17. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D and Parsons R: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57: 4183-4186, 1997.
18. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39, 1998.
19. Zhang D, Lim S and Koay ESC: Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinomas. Int J Oncol 31: 577-584, 2007.
20. Siomi H and Dreyfuss G: RNA-binding proteins as regulators of gene expression. Curr Opin Genet Dev 7: 345-353, 1997.
21. Taira T, Iguchi-Ariga SM and Ariga H: Co-localization withDJ-1 is essential for the androgen receptor to exert its transcription activity that has been impaired by androgen antagonists. Biol Pharm Bull 27: 574-577, 2004.
22. Zhang L, Shimoji M, Thomas B, Moore DJ, Yu SW, Marupudi NI, Torp R, Torgner A, Ottersen OP, Dawson TM and Dawson VL: Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum Mol Genet 14: 2063-2073, 2005.
23. Junn E, Jang WH, Zhao X, Jeong BS and Mouradian MM: Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. J Neurosci Res 87: 123-129, 2009.
24. Tillman JE, Yuan J, Gu G, Fazli L, Ghosh R, Flynt AS, Gleave M, Rennie PS and Kasper S: DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells. Cancer Res 67: 4630-4637, 2007.